Back to results
US 2012/0251559 A1Published application
Treatment of B-Cell Cancers With Anti-CD70 Antibody-Drug Conjugates
AssigneeSeattle Genetics, Inc.
InventorsChe-Leung Law, Alan F. Wahl, Nathalie Scholler, Linda A. Pestano
Life of this patent
Estimating the term…
Abstract
Disclosed are anti-CD70 antibodies and derivatives thereof conjugated to cytotoxic therapeutic agents, as well as pharmaceutical compositions and kits comprising the antibody- and antibody derivative-drug conjugates. Also disclosed are methods, for the treatment of a CD70-expressing cancer, comprising administering to a subject the disclosed pharmaceutical compositions.
Claims25
A method for the treatment of a CD70-expressing cancer of a B-cell lineage in a human subject, the method comprising:
- administering to the subject, in an amount effective for the treatment thereof, an antibody-drug conjugate comprising an antibody that specifically binds to CD70, wherein:
- (i) the drug is a cytotoxic agent, and
- (ii) the antibody-drug conjugate is internalized into cells, where it exerts a therapeutic effect.
Dependencies are inferred from the claim text.